Mohlo by sa vám tiež páčiť

Viac informácií o knihe Bortezomib in the Treatment of Multiple Myeloma

• Parametre knihy
• Anotácia kniha
• Obľúbené z iného súdka

Nákupom získate 345 bodov

Anotácia knihy

Multiple Myeloma (MM) is the second most-common blood cancer, resulting from overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promising anticancer-drug targeting the proteasome. This proteasome inhibitor induces cell stress and apoptosis in the cancer cells. While multiple mechanisms are likely to be involved, proteasome inhibition may prevent degradation of pro-apoptotic factors, permitting activation of programmed cell death in neoplastic cells dependent upon suppression of pro-apoptotic pathways.§This monograph on bortezomib is a valuable source of information for researchers and clinicians from oncology and pharmacology, working either in academia or the pharmaceutical industry.

Parametre knihy

Zaradenie knihy Knihy po anglicky Medicine Clinical & internal medicine Diseases & disorders

• Celý názov: Bortezomib in the Treatment of Multiple Myeloma
• Autor: Irene M. Ghobrial, Paul G. Richardson, Kenneth C. Anderson
• Jazyk: Angličtina
• Väzba: Pevná
• Počet strán: 180
• EAN: 9783764389475
• ISBN: 3764389478
• ID: 01717171
• Nakladateľ: Birkhauser Verlag AG
• Hmotnosť: 416 g
• Rozmery: 243 × 158 × 13 mm
• Dátum vydania: 28. January 2010

Obľúbené z iného súdka

---

---

---